Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates-Reference-Cited by-同舟云学术

Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates

Published:2020-02-11 Issue:2 Volume:15 Page:e0228572
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Liu Xueqiao,Liang Bo,Liu Xiang,Amaro-Carambot Emerito,Surman Sonja,Kwong Peter D.,Graham Barney S.,Collins Peter L.,Munir Shirin^ORCID

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Taxonomy of the order Mononegavirales: update 2016;CL Afonso;Archives of virology,2016

2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;H Nair;Lancet,2010

3. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;R Lozano;Lancet,2012

4. Architecture of respiratory syncytial virus revealed by electron cryotomography;L Liljeroos;Proceedings of the National Academy of Sciences of the United States of America,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview;Heliyon;2024-08

2. Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3;Veterinary Research;2024-06-27

3. Intranasal murine pneumonia virus-vectored SARS-CoV-2 vaccine induces mucosal and serum antibodies in macaques;iScience;2023-12

4. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections;Pharmaceutical Research;2023-04-25

5. Cross-protective antibodies against common endemic respiratory viruses;Nature Communications;2023-02-13